Oct. 23 at 5:13 AM
$CRSR $CRSR
This is the latest research numbers from the analysts at Craig-Hellum who recently initiated coverage. This is 2024, 2025 and 2026. Despite the claims that no growth is expected, growth is actually expected.
It is not hard to justify a
$10 short term target price if you believe these numbers are plausible.
This is not saying that the last few years have not had poor performance. This is saying that those years are in the past and already reflected in the lower stock price which should go higher with improving numbers.
EBITDA
Q1 18.0 22.6A 27.1
Q2 (1.2) 8.1A 11.3
Q3 4.8 15.1 23.2
Q4 33.1 43.4 58.2
FY 54.7 89.3 119.9
